Shanghai Allist Pharmaceuticals Co Ltd 688578.SS

Last Updated: May 15, 12:00 AM·SSE

688578.SS Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: September 06, 2025

Report Source: 2025 2nd Quarter Report

Shanghai Allist Pharmaceuticals Co Ltd

Shanghai Allist Pharmaceuticals Co Ltd. Stock Analysis 688578.SS

China Health Care Mid Cap Report:
Shanghai Allist Pharmaceuticals Co., Ltd. engages in the innovative pharmaceutical company in the field of cancer treatment. The company is headquartered in Shanghai, Shanghai and currently employs 1,989 full-time employees. The company went IPO on 2020-12-02. The firm has developed a pipeline of small molecule targeted drugs for non-small cell lung cancer. The main products include Furmonertinib Mesilate tablets, golecilex and pratinib capsules. The primary business includes sales of anti-cancer products, as well as technology licensing and services. The firm mainly operates in the domestic market.
Read More
Lock image
crown-icon

Shariah Compliance Report

An extensive business and financial screening of the company which specifies why a stock is halal or haram!

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.